Spyre Therapeutics, Inc. (SYRE) operating KPIs

SYRENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 7/30

$96.56−2.40 (-2.43%)

Close on Oct 30, 2026Market cap $8.51BP/E –Yield –

KPIs

Operating metrics that drive Spyre Therapeutics's business

Coming soon

This tab will track the numbers specific to Spyre Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.